Neoadjuvant Chemoradiation for Non ‐Metastatic Pancreatic Cancer Increases Margin Negative and Node Negative Rates at Resection

ConclusionsNeoadjuvant chemoradiation remains a promising approach for non‐metastatic pancreatic cancer to improve resectability and pathologic and clinical findings. CT may not fully demonstrate the effectiveness of neoadjuvant treatment.

Source: Journal of Digestive Diseases - October 20, 2017 Category: Gastroenterology Authors: Camille A. Berriochoa, May Abdel ‐Wahab, Charles Marc Leyrer, Alok Khorana, R. Matthew Walsh, Aryavarta M. S. Kumar Tags: Original article Source Type: research